Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boehringer Ingelheim
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Female and male patients \>= 40 years
COPD GOLD 2014 B - D
Treatment with Spiriva® Respimat® plus Striverdi® Respimat® or Spiriva® 18 Microgramm plus Striverdi® Respimat® acc. to the Summary of Product Characteristics (SmPC), no change of routine diagnostics and treatment
Signed informed consent form before inclusion into the non-interventional study (NIS)
You may not be if
Patients with contraindications acc. to the Summary of Product Characteristics (SmPC)
pregnant and breastfeeding women
patients who are taking part in a different non-interventional study (NIS) or an interventional clinical study at the same time are not to be enrolled
Clareo Health | Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation Therapy
